| http://www.w3.org/ns/prov#value | - The new Shanghai facility, due to open in the second half of 2011, will focus on the discovery and development of antidiabetics with novel mechanisms of action, along with treatments that target co-morbid conditions such as cardiovascular disease and obesity.
|
